OncoSil Medical – New Technology to Provide Safer Radiotherapy Treatments for Pancreatic Cancer
Radiation therapy has been used for many decades to treat cancer by using high-energy to destroy rapidly dividing tumour cells. OncoSil™ is a novel and safer form of radiation therapy that is localised to a pancreatic tumour, producing no systemic side effects.
OncoSil Medical’s strategic radiation therapy with a nuclear medicine focus is in three major and distinct unique advantages
- Localised therapy for solid tumours
- Ease of administration
- Improving patients quality of life
OncoSil Medical’s core technology includes the application of radioactive phosphorus (P32) to patients to control tumour growth. The company has spent many years perfecting the production of uniform micro particles (30 micron) that combine a radioactive material with inert silicon.
Share Price ASX: OSL AUD 0.087 as of "12/24/2014"